Stifel Financial’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Stifel Financial’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$486	Hold	16,000	–	–	﹤0.01%	3702
2026 Q1	$325	Hold	16,000	–	–	﹤0.01%	3624
2025 Q4	$416	Hold	16,000	–	–	﹤0.01%	3565
2025 Q3	$563	Hold	16,000	–	–	﹤0.01%	3531
2025 Q2	$654	Hold	16,000	–	–	﹤0.01%	3462
2025 Q1	$1.22K	Hold	16,000	–	–	﹤0.01%	3445
2024 Q4	$542	Hold	16,000	–	–	﹤0.01%	3372
2024 Q3	$504	Buy	+16,000	New	+$926	﹤0.01%	3361

Other funds holding SLXNW

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Stifel Financial's SLXNW Position: Q2 2026 in Review

Stifel Financial held its Silexion Therapeutics Warrant (SLXNW) position steady in Q2 2026 at 16,000 shares worth $486. The position accounts for ﹤0.01% of the portfolio, ranked #3702.

Stifel Financial first reported a position in SLXNW in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.22K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q2 2026.

Stifel Financial held 16,000 shares of Silexion Therapeutics Warrant worth $486 as of Q2 2026.
Stifel Financial left its Silexion Therapeutics Warrant share count unchanged in Q2 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3702 holding.
Stifel Financial first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 8 quarters since.
Stifel Financial's Silexion Therapeutics Warrant position peaked at $1.22K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.